Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis.

Authors :: Salem JE
Allenbach Y
Vozy A
Brechot N
Johnson DB
Moslehi JJ
Kerneis M
Source :: The New England journal of medicine [N Engl J Med] 2019 Jun 13; Vol. 380 (24), pp. 2377-2379.
Publication Year :: 2019

Subjects :: Aged
Female
Humans
Immunosuppressive Agents adverse effects
Lung Neoplasms drug therapy
Myocarditis chemically induced
Myositis chemically induced
Abatacept therapeutic use
Antineoplastic Agents, Immunological adverse effects
Myocarditis drug therapy
Nivolumab adverse effects
Programmed Cell Death 1 Receptor antagonists & inhibitors

Full Text Access

Tools